Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.

Author: ArnaudC D, BjarnasonN H, ChristiansenC, CohenF J, DelmasP D, DraperM W, GennariC, HarperK D, HeathH, HusterW, JohnstonC C, LindsayR, MitlakB H, ShahA

Paper Details 
Original Abstract of the Article :
In postmenopausal women, raloxifene hydrochloride has favorable effects on bone and lipid metabolism and does not stimulate reproductive tissues. The studies reported herein evaluated the long-term (3-year) effects of raloxifene treatment on bone mineral density (BMD), serum lipid levels, and drug t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1001/archinte.160.22.3444

データ提供:米国国立医学図書館(NLM)

Long-term Effects of Raloxifene on Bone Mineral Density

This research delves into the realm of [bone health] and presents a valuable study on the long-term impacts of raloxifene, a medication known for its effects on bone and lipid metabolism. It’s like a camel navigating a desert, finding an oasis of knowledge about bone health in the vast expanse of medical research. The study utilized [two double-blind, randomized, placebo-controlled trials] to assess the effects of raloxifene on [bone mineral density, bone turnover, and serum lipid levels] in women who have entered menopause, a transition marked by hormonal changes. The researchers found that raloxifene had a positive impact on bone and lipid metabolism, a finding that could be very beneficial for women in the later stages of their lives.

Raloxifene's Potential for Bone Health

This research suggests that raloxifene may play a significant role in [improving bone health] in postmenopausal women. This is particularly important because [osteoporosis] is a common condition among older women, leading to increased risk of fractures. The results of this study provide evidence that raloxifene could be a valuable tool for mitigating this risk, potentially leading to improved bone health and a reduced chance of fractures.

Living a Healthy Life with Raloxifene

The findings of this research point towards the potential benefits of raloxifene in [improving bone health and reducing lipid levels] in postmenopausal women. However, it is crucial to [consult with a healthcare professional] before starting any new medication, especially if you have pre-existing conditions or are taking other medications. As a camel navigating the vast desert of health information, I encourage you to be cautious and seek professional advice.

Dr. Camel's Conclusion

Raloxifene, like a cool oasis in a vast desert, might offer a respite for women dealing with bone health concerns after menopause. However, it is important to remember that every camel is unique, and what works for one might not work for another. Consult a healthcare professional to navigate the best path for your individual needs.
Date :
  1. Date Completed 2001-01-11
  2. Date Revised 2019-08-13
Further Info :

Pubmed ID

11112238

DOI: Digital Object Identifier

10.1001/archinte.160.22.3444

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.